NDAINTRAVENOUSPOWDERPriority Review
Approved
Nov 2022
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SEZABY is an intravenous powder formulation of phenobarbital sodium, a long-acting barbiturate approved by the FDA in November 2022. This product is indicated for acute seizure management and status epilepticus in patients requiring rapid parenteral anticonvulsant therapy. Phenobarbital sodium works by enhancing GABAergic inhibition in the central nervous system, thereby suppressing seizure activity.
Peak15.9 years to LOE
As a recently approved product in peak lifecycle stage with a reformulated IV powder delivery, the SEZABY brand team is likely actively building market presence in acute care segments with growing sales and commercial infrastructure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
SEZABY roles are centered in commercial and hospital-focused teams, with emphasis on acute care market penetration and formulary management. Career opportunities are concentrated in field-based and hospital account management positions targeting emergency departments and intensive care units.
Brand ManagerHospital Account Manager
Worked on SEZABY at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.